Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 12 (1) , 62-66
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of University and Scientific Research (Sapienza University of Rome)
This publication has 26 references indexed in Scilit:
- Pharmacological activity of a Bv8 analogue modified in position 24British Journal of Pharmacology, 2012
- The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory painProceedings of the National Academy of Sciences, 2009
- Possible Association of Prokineticin 2 Receptor Gene (PROKR2) with Mood Disorders in the Japanese PopulationNeuroMolecular Medicine, 2009
- Chapter 11 Bv8/Prokineticins and their Receptors2009
- Prokineticins and the heart: diverging actions elicited by signalling through prokineticin receptor-1 or -2Cardiovascular Research, 2008
- Cytokine properties of prokineticinsThe FEBS Journal, 2008
- Bv8 regulates myeloid-cell-dependent tumour angiogenesisNature, 2007
- The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the ratEuropean Journal of Neuroscience, 2007
- Impaired Nociception and Inflammatory Pain Sensation in Mice Lacking the Prokineticin Receptor PKR1: Focus on Interaction between PKR1 and the Capsaicin Receptor TRPV1 in Pain BehaviorJournal of Neuroscience, 2006
- Sensitization of Transient Receptor Potential Vanilloid 1 by the Prokineticin Receptor Agonist Bv8Journal of Neuroscience, 2006